Incubation-period estimates of Omicron (BA.1) variant from Taiwan, December 2021-January 2022, and its comparison to other SARS-CoV-2 variants: a statistical modeling, systematic search and meta-analysis

Background: The ongoing COVID-19 pandemic has seen several variants of concern, including the Omicron (BA.1) variant which emerged in October 2021. Accurately estimating the incubation period of these variants is crucial for predicting disease spread and formulating effective public health strategies. However, existing estimates often conflict because of biases arising from the dynamic nature of epidemic growth and selective inclusion of cases. This study aims to accurately estimate of the Omicron (BA.1) variant incubation period based on data from Taiwan, where disease incidence remained low and contact tracing was comprehensive during the first months of the Omicron outbreak. Methods: We reviewed 100 contact-tracing records for cases of the Omicron BA.1 variant reported between December 2021 and January 2022, and found enough information to analyze 70 of these. The incubation period distribution was estimated by fitting data on exposure and symptom onset within a Bayesian mixture model using gamma, Weibull, and lognormal distributions as candidates. Additionally, a systematic literature search was conducted to accumulate data for estimates of the incubation period for Omicron (BA.1/2, BA.4/5) subvariants, which was then used for meta-analysis and comparison. Results: The mean incubation period was estimated at 3.5 days (95% credible interval: 3.1-4.0 days), with no clear differences when stratified by vaccination status or age. This estimate aligns closely with the pooled mean of 3.4 days (3.0-3.8 days) obtained from a meta-analysis of other published studies on Omicron subvariants. Conclusions: The relatively shorter incubation period of the Omicron variant, as compared to previous SARS-CoV2 variants, implies its potential for rapid spread but also opens the possibility for individuals to voluntarily adopt shorter, more resource-efficient quarantine periods. Continual updates to incubation period estimates, utilizing data from comprehensive contact tracing, are crucial for effectively guiding these voluntary actions and adjusting high socio-economic cost interventions.

[1]  A. Kucharski,et al.  Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants , 2023, medRxiv.

[2]  J. Wise Covid-19: WHO declares end of global health emergency , 2023, BMJ.

[3]  H. Kuo,et al.  Epidemiological characteristics of the three waves of COVID-19 epidemic in Taiwan during April 2022 to March 2023 , 2023, Journal of the Formosan Medical Association = Taiwan yi zhi.

[4]  Hongbiao Chen,et al.  High-rise buildings: A risk factor in the COVID-19 Omicron epidemic period , 2023, Public health in practice.

[5]  S. Cauchemez,et al.  SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study , 2023, The Lancet. Microbe.

[6]  Hung-Yu Shu,et al.  Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan , 2023, Emerging infectious diseases.

[7]  A. Soong,et al.  Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore , 2023, Emerging infectious diseases.

[8]  K. Wang,et al.  Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China , 2023, JAMA network open.

[9]  E. Yeoh,et al.  Comparing the incubation period, serial interval, and infectiousness profile between SARS‐CoV‐2 Omicron and Delta variants , 2023, Journal of medical virology.

[10]  T. Ogata,et al.  SARS-CoV-2 Incubation Period during the Omicron BA.5–Dominant Period in Japan , 2023, Emerging infectious diseases.

[11]  B. Cowling,et al.  Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022 , 2022, International Journal of Infectious Diseases.

[12]  Qianhui Wu,et al.  Household transmission of SARS‐CoV‐2 during the Omicron wave in Shanghai, China: A case‐ascertained study , 2022, medRxiv.

[13]  J. Dushoff,et al.  Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2 , 2022, medRxiv.

[14]  S. Merler,et al.  Intrinsic generation time of the SARS-CoV-2 Omicron variant: An observational study of household transmission , 2022, The Lancet Regional Health - Europe.

[15]  G. Bálint,et al.  Omicron: increased transmissibility and decreased pathogenicity , 2022, Signal Transduction and Targeted Therapy.

[16]  Toshiyuki Shibata,et al.  Shorter Incubation Period among COVID-19 Cases with the BA.1 Omicron Variant , 2022, International journal of environmental research and public health.

[17]  E. Lau,et al.  Shorter serial intervals and incubation periods in SARS-CoV-2 variants than the SARS-CoV-2 ancestral strain , 2022, Journal of travel medicine.

[18]  S. Shafer Intrinsic Severity of the SARS-CoV-2 Omicron Variant. , 2022, The New England journal of medicine.

[19]  J. Dushoff,et al.  Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa , 2022, Science.

[20]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[21]  B. Cowling,et al.  Omicron severity: milder but not mild , 2022, The Lancet.

[22]  Kimihito Ito,et al.  Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark , 2021, Journal of medical virology.

[23]  M. Kraemer,et al.  Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.

[24]  F. Campo Review of: "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant" , 2021, Qeios.

[25]  S. Madhi,et al.  Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant , 2021, The New England Journal of Medicine.

[26]  Kwang Su Kim,et al.  Estimation of the incubation period of COVID-19 using viral load data , 2020, Epidemics.

[27]  Luke O'Grady,et al.  Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research , 2020, BMJ Open.

[28]  N. Linton,et al.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.

[29]  M. Keller,et al.  Bayesian model averaging via mixture model estimation , 2017, 1711.10016.

[30]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[31]  W. Team,et al.  West African Ebola Epidemic after One Year — Slowing but Not Yet under Control , 2015 .

[32]  R. Brookmeyer,et al.  Estimating incubation period distributions with coarse data , 2009, Statistics in medicine.

[33]  Mikiko Senga,et al.  Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. , 2014, The New England journal of medicine.